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Abstract 37 
Purpose Fine particulate matter (PM2.5) is considered to be one of the most important 38 
environmental factors contributing to the global human disease burden. However, due to the 39 
lack of broad consensus and harmonization in the life cycle assessment (LCA) community, 40 
there is no clear guidance on how to consistently include health effects from PM2.5 exposure 41 
in LCA practice. As a consequence, different models are currently used to assess life cycle 42 
impacts for PM2.5, sometimes leading to inconsistent results. In a global effort initiated by the 43 
UNEP/SETAC Life Cycle Initiative, respiratory inorganics impacts expressed as health 44 
effects from PM2.5 exposure were selected as one of the initial impact categories to undergo 45 
review with the goal of providing global guidance for implementation in life cycle impact 46 
assessment (LCIA). The goal of this paper is to summarize the current knowledge and 47 
practice for assessing health effects from PM2.5 exposure and to provide recommendations for 48 
their consistent integration into LCIA. 49 
Methods A task force on human health impacts was convened to build the framework for 50 
consistently quantifying health effects from PM2.5 exposure and for recommending PM2.5 51 
characterization factors. In an initial Guidance Workshop, existing literature was reviewed 52 
and input from a broad range of internationally-recognized experts was obtained and 53 
discussed. Workshop objectives were to identify the main scientific questions and challenges 54 
for quantifying health effects from PM2.5 exposure, and to provide initial guidance to the 55 
impact quantification process. 56 
Results and recommendations A set of 10 recommendations was developed addressing: 57 
(a) the general framework for assessing PM2.5-related health effects, (b) approaches and data 58 
to estimate human exposure to PM2.5 using intake fractions, and (c) approaches and data to 59 
characterize exposure-response functions (ERF) for PM2.5 and to quantify severity of the 60 
diseases attributed to PM2.5 exposure. Despite these advances, a number of complex issues, 61 
such as those related to non-linearity of the ERF and the possible need to provide different 62 
ERF’s for use in different geographic regions, require further analysis. 63 
Conclusions and outlook Questions of how to refine and improve the overall framework 64 
were analyzed. Data and models were proposed for harmonizing various elements of the 65 
health impact pathways for PM2.5. Within the next two years, our goal is to build a global 66 
guidance framework and to determine characterization factors that are more reliable for 67 
incorporating the health effects from exposure to PM2.5 into LCIA. Ideally, this will allow 68 
quantification of the impacts of both indoor and outdoor exposure to PM2.5. 69 
 70 
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1 Health effects from fine particulate matter: Towards global guidance in life cycle 75 
assessment 76 
Life cycle assessment (LCA) is a structured, comprehensive, and internationally 77 
standardized method to assess potential environmental impacts and resources used throughout 78 
the life cycle of a good or service in a comparable way (ISO 2006). LCA thereby aims for 79 
best estimates in the modelling of all relevant impacts on the natural environment, human 80 
health, and resources in the life cycle impact assessment (LCIA) phase (EC 2010a, Finnveden 81 
et al. 2009). To help identify best LCA practice, Phase III (2012-2016) of the UNEP/SETAC 82 
Life Cycle Initiative
1
 has launched a flagship project aiming to provide global guidance and 83 
consensus on a limited number of LCIA indicators. The Glasgow Scoping Workshop in May 84 
2013 (Jolliet et al. 2014) focused on establishing a tentative short list of impact category 85 
indicators that would be addressed during two consensus building periods. These indicators 86 
included the impacts of respiratory inorganics expressed as health effects from exposure to 87 
primary and secondary particulate matter (PM), which is considered to be one of the most 88 
important environmental stressors contributing to the global human disease burden (Hänninen 89 
et al. 2014, Lim et al. 2012). Primary PM refers to directly emitted particles. Secondary PM 90 
refers to organic and inorganic (e.g. ammonium nitrate, ammonium sulfate) particles formed 91 
through reactions of precursor substances including nitrogen oxides (NOx), sulfur oxides 92 
(SOx), ammonia (NH3), semivolatile and volatile organic compounds (VOC), of which the 93 
latter are most important for secondary organic aerosol formation. PM is further distinguished 94 
according to aerodynamic diameter, i.e. respirable particles (PM10) with <10 µm, fine 95 
particles (PM2.5) with <2.5 µm, and ultrafine particles (UFP) with <100 nm aerodynamic 96 
diameter (WHO 2006). PM2.5 was chosen to provide international recommendations regarding 97 
the consistent integration of its health effects into LCIA because it might best describe the 98 
component of particulate matter responsible for adverse health effects (Harrison & Yin 2000, 99 
Lim et al. 2012, Lippmann & Chen 2009). 100 
 101 
2 Assessing fine particulate matter in the context of life cycle impact assessment 102 
In epidemiological studies, exposure to PM2.5 is associated with various adverse health 103 
effects and reduction in life expectancy including chronic and acute respiratory and 104 
cardiovascular morbidity, chronic and acute mortality, lung cancer, diabetes, and adverse birth 105 
outcomes (Beelen et al. 2014, Brook et al. 2010, Chen et al. 2008, COMEAP 2010, Dadvand 106 
et al. 2013, Hoek et al. 2013, Künzli et al. 2000, Lippmann & Chen 2009, Loomis et al. 2013, 107 
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Mehta et al. 2013, Pelucchi et al. 2009, Pope III et al. 2009, Pope III et al. 2011, Straif et al. 108 
2013). Furthermore, toxicological studies support the observation that exposure to PM2.5 can 109 
exert effects on key biological systems, with some evidence that not all particles are likely to 110 
cause the same health effects (Harrison & Yin 2000, Kelly & Fussell 2012, Rohr & Wyzga 111 
2012, Stanek et al. 2011). Several existing LCIA methods already characterize health effects 112 
associated with ambient PM or PM2.5 concentrations (EC 2010c), mostly based on ambient 113 
PM2.5 intake estimated from simple exposure or intake fraction models and using health effect 114 
data from the Harvard Six Cities and American Cancer Society studies (Krewski et al. 2000, 115 
Laden et al. 2006, Pope III et al. 2002). A few studies include spatial allocation of emissions 116 
and modeling of air dispersion and chemical reactions to predict downwind PM2.5 117 
concentrations (Hill et al. 2009, Tessum et al. 2012). Whenever emission locations are known, 118 
these spatially-explicit approaches can be applied in LCIA. It is anticipated in the future to 119 
fully assess PM2.5 impacts using such spatially explicit approaches. In the current absence of 120 
this capacity,  a consistent and globally harmonized approach for LCIA should be based on 121 
the most recent science to simultaneously address environmental fate, human exposure, and 122 
health effects of PM2.5 concentrations resulting from emissions of primary PM2.5 and 123 
secondary PM2.5 precursors (Hauschild et al. 2013). 124 
One of the challenges in LCA is that impacts are linked to emissions via intake, whereas 125 
in epidemiology, impacts are related to concentrations. Generally, when assessing the health 126 
response of a population, the most accurate and efficient approach is to relate observed 127 
concentrations to population response. This also constitutes the basis for the LCA framework. 128 
However, this approach needs to be adapted for the emission-based LCA context for which 129 
the impact of an additional kg emitted by multiple sources in different, often unknown 130 
locations needs to be evaluated (Finnveden et al. 2009, Hauschild 2005). For such emission-131 
based assessments, the human intake fraction (iF) as the fraction of an emitted mass 132 
ultimately taken in by the total exposed population is well adapted, accounting directly for a 133 
temporally and spatially integrated concentration multiplied by nominal human intake rates. 134 
Intake fraction is a time- and space-integrated metric, easy to understand, to communicate and 135 
to combine with chemical emissions. Emission source types can be associated with specific 136 
iF, which is easier to interface and combine at the level of exposure than a field of 137 
concentrations over a certain distance around the source. 138 
With respect to assessing the particular health effects from PM2.5 exposure, the effort of 139 
an earlier UNEP/SETAC working group has designed a framework and proposed a set of 140 
default iF associated with PM2.5 emissions for use in LCIA (Humbert et al. 2011). This effort 141 
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is limited to the steps of the impact pathway from emissions to concentration and human 142 
intake, but does not cover the steps from human intake to health effects. In addition, due to 143 
the lack of broad consensus and harmonization in the LCA community, there is no clear 144 
guidance on how to include health effects from PM2.5 exposure in LCA practice. As a 145 
consequence, different models are currently used leading at times to inconsistent life cycle 146 
impact results reported for this category. This reveals the importance of pursuing consensus 147 
building, based on the initial work of Humbert et al. (2011) and combining it with latest 148 
exposure-response and severity data to yield revised guidance on the development and use of 149 
human health characterization factors for both primary and secondary PM2.5 including 150 
precursor substances. Ultrafine particles are currently not separately considered in LCA. 151 
To meet our needs for global guidance and harmonization regarding health effects from 152 
PM2.5 exposure in LCIA, the UNEP/SETAC Life Cycle Initiative established a task force on 153 
human health impacts. The aim of the task force is to build within the next two years a 154 
framework and determine factors recommended for incorporating human health effects from 155 
PM2.5 exposure into LCIA and addressing both outdoor and indoor releases. In order to 156 
provide a starting point for the task force effort, the workshop participants summarize in this 157 
paper the current knowledge on and practice in assessing the health effects from PM2.5 158 
exposure including related recommendations. 159 
 160 
3 The Basel Guidance Workshop: Identifying and addressing the key questions 161 
Within the task force on human health impacts, an initial Guidance Workshop was 162 
organized back-to-back with the ISEE/ISES/ISIAQ Environment and Health Conference in 163 
Basel, Switzerland, in August 2013. Based on a literature review and expert input, the 164 
workshop organizers reached out to a broad range of internationally recognized experts in PM 165 
exposure and health effects. Sixteen of these experts agreed both to participate in the process 166 
and attend the Basel workshop (in person or by phone). This included experts from Canada, 167 
Denmark, Finland, Germany, Poland, Spain, Switzerland, the United Kingdom, and the 168 
United States. Many others have agreed to contribute in some form to the task force activities. 169 
The specific objectives of the workshop were to first identify and discuss the main 170 
scientific questions and challenges for quantifying human health effects from PM2.5 exposure, 171 
and then to provide initial guidance to the impact quantification process. Three main topics 172 
were addressed at the workshop: (a) the general assessment framework as proposed by 173 
Humbert et al. (2011), (b) approaches and data to determine human exposure to PM2.5 174 
expressed as intake fractions, and (c) approaches and data to determine exposure-response 175 
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functions (ERF) for PM2.5 along with disease severity. For these topics, the workshop 176 
participants discussed a set of key questions that had been established with selected experts in 177 
three pre-workshop phone conferences. Table 1 summarizes these key questions, which are 178 
discussed in detail in the following. 179 
 180 
Table 1 Key questions discussed during the Basel Guidance Workshop 181 
1. General assessment framework 
 Can we use the framework that is proposed in Figure 1 based on work from Humbert et 
al. (2011) to include health effects from respiration of ambient particulate matter into 
life cycle impact assessment? 
2. Human intake fraction 
 What additional factors/aspects will we have to take into account, i.e. those that 
substantially influence intake fractions by at least a factor of two? 
 Can we use archetypes to disaggregate aspects influencing intake fractions (emission 
stack height, primary/secondary particulates, particle size, and urban/rural/remote area) 
and what archetypal structure is meaningful? 
 What is the added value of applying archetypes for emission sources (e.g. road 
transport) or specific regions (e.g. China)? 
 How do we arrive at a consistent set of emission-weighted average intake fractions? 
 Which existing studies, methods, and models are best or most usefully suited as 
starting points for arriving at a consistent set of intake fractions to improve factors 
stated in Humbert et al. (2011)? 
 How can we properly address in life cycle impact assessment the combined 
environmental fate aspects of ammonia, nitrogen oxides, and sulfur oxides? 
3. Exposure-response functions and effect evaluation 
 What are the major studies that we need to take into account to determine exposure-
response functions for relevant health effects? 
 In addition to cardiovascular diseases and lung cancer, is it relevant to include other 
health effects, such as bronchitis or asthma in children? 
 To what extent are exposure-response functions available for the fraction of 
particulates with an aerodynamic diameter below 2.5 µm and what alternative approach 
would be applicable? 
 Are there any emerging studies that would challenge our default approach? 
 Are there studies providing evidence and specific exposure-response functions for 
differentiated effects for primary and secondary particulates? 
 What relevant exposure studies are available for exposure to particulates from indoor 
sources and for outdoor particulates emissions in different parts of the world? 
 How far can studies focusing on the United States (or studies mentioned under the first 
question of point 3) be applied as a default for different parts of the world or for indoor 
exposure to particulates? 
 How can we consistently account for the severity of different (mortality and morbidity) 
health effects based on disability weights? 
 How can damage measures be suggested in order of priority in terms of health effects? 
4. Additional remarks 
 What additional comments or recommendations could improve the set of intake 
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fractions, exposure-response functions and severity factors? 
 182 
4 General assessment framework recommendations 183 
An overall picture of the approach currently proposed for health effects attributed to 184 
PM2.5 exposure in LCIA including the findings of the Basel guidance workshop is presented 185 
in Figure 1. 186 
 187 
 188 
Figure 1 Proposed framework for assessing human health effects from fine particulate matter 189 
exposure in life cycle impact assessment; adapted from Humbert et al. (2011). 190 
 191 
4.1 Overall assessment approach 192 
There was agreement among the workshop participants to build upon the general 193 
framework proposed by Humbert et al. (2011). In this framework, human intake fractions for 194 
primary and secondary PM2.5 are provided, emissions from low and high stacks are 195 
differentiated, and dominant influences for generic landscape characteristics are 196 
parameterized. Humbert et al. (2011) thereby start from emissions of primary PM2.5 and 197 
secondary PM2.5 precursors into the environment, m (mass emitted), and multiply these 198 
emissions with intake fractions, iF (mass of PM2.5 inhaled by the affected population per mass 199 
of primary PM2.5 or secondary PM2.5 precursor emitted, respectively), an exposure-response 200 
factor derived from epidemiological studies linking health effects in the affected population to 201 
ambient PM2.5 concentrations,
2
 ERF (disease rate per unit mass concentration), and a severity 202 
                                                 
2
 PM2.5 concentrations can be converted to intake using the breathing rate of the exposed population. How to 
average the breathing rate for different activities, age, etc. remains to be further discussed. 
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factor, SF (disability-adjusted life years, DALY per disease case), to arrive at a human health-203 
related impact score, IS (DALY): 204 

CF
SFERFiFmIS               (1) 205 
Intake fraction, exposure-response factor and severity factor can be represented by the 206 
characterization factor, CF (DALY per mass emitted). A key assumption implicit in this 207 
framework is the linear, no-threshold ERF. While not uncontroversial, this assumption 208 
reflects current practice and recent recommendations in LCIA (EC 2010b, Potting et al. 209 
2007), and is also applied in other studies as discussed e.g. in COMEAP (2009). 210 
 211 
4.2 Exposure metrics 212 
Two exposure metrics, (i) ambient PM2.5 concentration, and (ii) population intake of PM2.5, 213 
were considered as possible starting points for assessing health impacts from PM2.5 exposure. 214 
It should be noted that, when all populations are assigned the same population breathing rate, 215 
the exposure expressed as either ambient concentration or intake fraction are exactly 216 
proportional. In other LCIA areas, health impacts are typically assessed using population 217 
intake as exposure metric (Udo de Haes et al. 2002). This approach can be justified for many 218 
endpoints, e.g. cancer risk assessment for genetic carcinogens, where risk is proportional to 219 
cumulative intake (often expressed as applied dose), i.e. where there are no population 220 
thresholds and no appreciable non-linearities in the relationship between intake and response. 221 
However, in cases where there are thresholds, i.e. concentrations or intakes below which 222 
health effects are not induced even in the most sensitive individuals, or significant non-223 
linearities in describing response as a function of concentration or cumulative intake, this 224 
simple approach may not provide a satisfactory representation of the effect of changes in 225 
exposure on population health risk. To make the approach more appropriate in such cases, the 226 
population intake fraction can be used as a measure of the population’s ambient PM2.5 227 
exposure. For population exposure to PM2.5, it is reasonable to assume no threshold, but there 228 
are possibilities for non-linear response for highly exposed populations (Burnett et al. 2014). 229 
Epidemiological studies of the health impacts of exposure to PM2.5 typically report the 230 
relative risk of morbidity or mortality (i.e., the ratio of the risk among the exposed to that 231 
among the unexposed) as a function of the concentration of PM2.5 measured at fixed site 232 
monitors (see, for example, COMEAP 2010). They are not based on concentrations found 233 
through personal exposure monitoring (Hurley et al. 2005). In LCIA, the impact of an 234 
additional kg often emitted by multiple sources at different, often unknown locations over the 235 
life cycle is evaluated, making it effectively impossible to report the related concentrations. 236 
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Recognizing the need for a population-scale exposure metric often without access to site-237 
specific emissions data, workshop participants recommended the use of population intake 238 
fraction, which is equivalent to population exposure concentration, as the default measure for 239 
computing PM2.5 health risks in LCIA. Population intake estimates computed using iF reflect 240 
the change in population-weighted intake of the ambient outdoor concentration. Thus, intake 241 
estimates are directly related to concentrations underlying epidemiological estimates of 242 
mortality and morbidity risks from PM2.5 exposure, although this requires knowledge about 243 
background concentrations when using non-linear exposure-response functions. 244 
 245 
4.3 Health metrics 246 
Various health metrics were discussed, including total and premature mortality, years of 247 
life lost (YLL), and disability-adjusted life years (DALY). Most workshop participants felt 248 
that when death is the outcome of interest, YLL is a better measure of mortality impacts than 249 
numbers of deaths. The view was that information on the number of deaths is more 250 
challenging to interpret because reduced PM2.5 intake cannot affect the fact of death, but only 251 
its cause and timing (Leksell & Rabl 2001, Rabl 2005). When it is necessary to combine 252 
mortality and morbidity impacts into a single summary measure, two approaches can be used. 253 
The first approach is to use DALY combining YLL and years lived with a disability (YLD) 254 
weighted by the quality of life during the period of disability (Murray & Lopez 1996b, 255 
Murray & Lopez 1996a). The second approach, which is frequently preferred by economists, 256 
is to use weights reflecting societal willingness to pay to avoid small incremental risks of 257 
mortality and morbidity. 258 
The workshop participants see no reason to reconsider this matter. In summary, YLL and 259 
DALY seem to be appropriate health metrics for use in LCIA, since they focus attention on 260 
actions with the greatest potential to lead to improvement in the number of healthy life years 261 
lived by the exposed populations (Wang et al. 2012). In addition, selecting a preferred 262 
approach is an issue that affects all analyses of health impacts in LCIA. Typically, LCIA has 263 
relied on the DALY metric (EC 2010b) without age-weighting and/or discounting. 264 
 265 
4.4 Other framework discussion points 266 
Two additional aspects were briefly discussed at the workshop: (i) whether and, if so, 267 
how to address the dynamics when expressing of health impacts attributable to PM2.5 268 
exposure, and (ii) how to account for differences between average and marginal impacts on 269 
health of primary and secondary PM2.5 precursor emissions, which may occur when either 270 
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emissions-exposure or exposure-response functions exhibit thresholds or significant non-271 
linearities. The workshop participants agreed that in the long-term both issues require further 272 
attention. 273 
 274 
5 From emissions to concentration and human intake: Determining intake fractions 275 
5.1 Archetypes structure 276 
In LCIA, it is common practice to make use of archetypal exposure scenarios, e.g. urban 277 
vs. rural scenarios (Riley et al. 2002), rather than site-specific exposure assessments, 278 
especially when emission locations are unknown. The workshop discussion focused on 279 
identifying the key factors influencing iF and determining how to address these in the context 280 
of quantifying PM2.5-related health effects in LCIA. Table 3 in Humbert et al. (2011) 281 
proposed one such archetypal structure in which population density (urban, rural, remote) and 282 
emission height (high-stack, low-stack, ground-level) serve as the main determinants of iF. 283 
Humbert et al. also provided a default set of iF values corresponding to these archetypes. 284 
Workshop participants agreed to adopt this structure as starting point, but pointed out that 285 
additional refinements in terms of archetypes need to be explored. Refinements can thereby 286 
build on applying a sensitivity analysis to a range of aspects that influence the variability of 287 
iF. This includes, for example, distinct urban areas based on work by Apte et al. (2012) and 288 
different emission sources, such as traffic-related sources (Greco et al. 2007, Lobscheid et al. 289 
2012, Marshall et al. 2005), stationary emissions from coal/gas-fired power plants (Heath et 290 
al. 2006, Levy et al. 2003, Levy et al. 2002), or indoor emissions from wood burning (Ries et 291 
al. 2009). The participants also agreed to include additional archetypes reflecting exposure 292 
from indoor emissions of PM2.5 based on work by Hellweg et al. (2009). 293 
 294 
5.2 Geographical differentiation 295 
Despite the availability of studies that examine the influence of geographical location and 296 
spatial resolution on PM2.5 concentrations and exposures (Kheirbek et al. 2013, Zhou et al. 297 
2006), questions remain about the level of geographical differentiation appropriate for LCIA 298 
and about how to properly characterize in LCIA the effects of differences in population age 299 
structure and disease incidence rates. Both issues appear to require further discussion. Based 300 
on that, workshop participants agreed that it would be useful to develop regional and/or 301 
continental sets of archetype-based iF to account for differences in environmental conditions 302 
(e.g. climate, precipitation, background concentration of secondary PM2.5 precursors), 303 
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exposure conditions (e.g. population density, stack height), and receptor attributes (e.g. 304 
population age structure, disease incidence rates). 305 
To account for differences in spatial scales, workshop participants suggested developing 306 
LCIA methods that differentiate between near-field (e.g. occupational settings; within 10 m), 307 
neighborhood (scale of a block; order of 100 m), urban (cities; order of 10-100 km), regional 308 
(order of 100-1,000 km), and continental scales (up to 10,000 km), thereby refining the 309 
archetypes used in Humbert et al. (2011). 310 
Workshop participants also discussed the complex interactions between emissions of 311 
NH3, NOx and SOx with respect to the formation and intake of secondary nitrates and sulfates. 312 
At the regional-continental scale, in areas with little agriculture and significant industrial 313 
activity (for example, along the east coast of the US), emissions of NH3 are a limiting factor 314 
for secondary PM2.5 formation, whereas in rural areas dominated by agriculture, NOx and SOx 315 
are more commonly the factors limiting the formation of secondary PM2.5 (Paulot & Jacob 316 
2014, Squizzato et al. 2013, Xu & Penner 2012). It was noted that geographically-resolved 317 
data for primary PM2.5 and secondary PM2.5 precursor emissions and iF for different emission 318 
heights are available for some regions (Apte et al. 2012, Levy et al. 2002, Pregger & Friedrich 319 
2009), but are not consistently available at the global level. It was agreed that in any attempt 320 
to differentiate geographic regions, particulate matter type (primary vs. secondary) is an 321 
important aspect to consider – secondary PM2.5 iF are less sensitive than primary PM2.5 iF to 322 
near source environmental, exposure and receptor characteristics (Humbert et al. 2011, Levy 323 
et al. 2003). 324 
 325 
5.3 Aggregation of intake fractions 326 
When combining iF from multiple sources, the appropriate approach is to multiply each 327 
emission’s iF by the magnitude of that emission, sum this product for all emissions being 328 
combined and then divide by the total emissions to obtain the emissions-weighted iF for all 329 
the individual emissions that are linked by their association with a given functional unit in an 330 
LCA. In cases where emissions are not well characterized, it can be assumed that emissions 331 
(e.g. from vehicles or energy production) are proportional to population (Humbert et al. 332 
2011). Population-weighted iF have been used in some studies as a proxy for emission-333 
weighted iF (Apte et al. 2012, Humbert et al. 2009), but other source- or sector-specific 334 
emission-weights exist to account for spatial correlations between source locations and 335 
population patterns (Levy et al. 2002, Lobscheid et al. 2012). 336 
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For all cases where the region, emission sources and locations, and/or population 337 
exposure conditions are unknown, it was agreed to use an emission-weighted average iF (i.e., 338 
site-generic) in the context of LCIA, as population intake is the result of multiplying iF by the 339 
corresponding emissions. To arrive at such emission-weights, the workshop participants 340 
suggested that the iF of each region/area (e.g. Indochina, Scandinavia) should be weighted 341 
according to the proportion of the contribution of this region to the total emission in the 342 
considered geographical domain (typically continental or global scale). This approach would 343 
be entirely consistent with previous efforts to develop iF values intended to be used to 344 
quantify the impact of PM2.5 or PM2.5 precursor emissions on ambient PM2.5 concentrations 345 
(Humbert et al. 2011, Levy et al. 2003, Marshall et al. 2003, Tainio et al. 2009). 346 
 347 
6 From concentration and human intake to health effects: Defining appropriate 348 
exposure-response functions 349 
6.1 Effect assessment starting point 350 
In LCIA, ERF link estimates of population exposure with estimates of health effects. 351 
Whereas some guidance is available on deriving PM2.5 intake fractions for use in LCIA 352 
(Humbert et al. 2011), guidance has not yet been established on the development of PM2.5 353 
exposure-response to support LCIA. 354 
Workshop participants agreed that models developed in support of the Global Burden of 355 
Disease Study (GBD) 2010 (Lim et al. 2012) may provide a reasonable framework for 356 
calculating health effects of PM2.5 exposure. GBD 2010 provides estimates of the health 357 
effects (expressed in DALY) caused by 67 risk factors for both 1990 and 2010. GBD 358 
estimates are provided for each of 21 world regions (based on epidemiological homogeneity 359 
and geographical contiguity) and are disaggregated by age (20 groups) and sex. PM2.5 as one 360 
of the considered risk factors was associated with five adverse health effects – ischemic heart 361 
disease, cerebrovascular disease, cancers of the trachea/bronchus or lung, chronic obstructive 362 
pulmonary disease among adults (≥25 years old), and lower respiratory infections among 363 
young children (≤5 years old). For these effects, risk estimates were developed using an 364 
integrated exposure-response (IER) function which provided cause-specific estimates of the 365 
relative risk as a function of the ambient PM2.5 concentration over a broad range of exposures 366 
from the counterfactual or threshold level to concentrations on the order of 100 μg/m3 367 
(Burnett et al. 2014). This model was labelled “integrated” because it combined evidence 368 
from studies of the health effects of ambient PM2.5 with studies of the effects of active and 369 
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passive smoking. Other health effects were not considered, because epidemiological evidence 370 
was either inconclusive or absent. 371 
GBD 2010 not only computes the relative risks of various health effects as a function of 372 
ambient PM2.5 concentrations, but also assigns DALY to each of the five health outcomes 373 
studied. In their 2010 analysis, GBD uses DALY that (a) are neither age-weighted nor 374 
discounted, (b) were derived using a counterfactual life expectancy at birth of 86 years for 375 
both males and females derived from the lowest age-specific death rates observed in any 376 
country (Murray et al. 2012), and (c) using disability weights derived from population-based 377 
household surveys involving 13,902 participants from Bangladesh, Indonesia, Peru, South 378 
Africa, Tanzania and the United States and an internet-based survey of 16,328 participants 379 
from 167 countries, 44% of whom were from the United States (Salomon et al. 2012). The 380 
approach applied in GBD 2010 to derive DALY that are not age-weighted or discounted, is 381 
consistent with current LCIA practice (EC 2010c). 382 
In summary, workshop participants consider the GBD 2010 models for the relative risks 383 
of the five health effects as a function of ambient PM2.5 concentrations as suitable starting 384 
points for developing ERF for use in LCIA. Because PM2.5 exposures associated with LCA 385 
applications and populations differ from those addressed in the GBD study, the question of 386 
whether the GBD 2010 disability weights for PM2.5 are well-suited to directly apply in LCIA 387 
requires further discussion. Currently, the workshop participants consider the GBD 2010 388 
disability weights a useful starting point. 389 
 390 
6.2 Health effects 391 
Health effects associated with PM2.5 exposure include a wide range of diseases. To date, 392 
PM exposure-response functions used in LCIA have focused on chronic and acute mortality 393 
and acute respiratory and cardiovascular morbidity associated with exposure to PM10 (van 394 
Zelm et al. 2008) or on cardiopulmonary mortality and lung cancer attributable to chronic 395 
exposure to PM2.5 (Gronlund et al. 2014). ERF have been derived using several approaches 396 
discussed in EC (2010c), primarily based on results from the Harvard Six Cities and 397 
American Cancer Society studies (Krewski et al. 2000, Laden et al. 2006, Pope III et al. 398 
2002). Although the impact of PM2.5 exposure on asthma has been reported in several 399 
epidemiological studies (Brauer et al. 2002, Kheirbek et al. 2013, Künzli et al. 2000), asthma 400 
is usually not considered in LCIA. At the workshop, it was noted that evidence linking PM2.5 401 
exposure with new asthma incidences is inconclusive, whereas it does support a link between 402 
PM2.5 exposure and the exacerbation of existing asthma (Donaldson et al. 2000, Gavett & 403 
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Koren 2001, Pope III et al. 1995). However, since it is unclear how to differentiate between 404 
induction of new cases and exacerbation of existing disease, there was no agreement on 405 
whether, and if so how, to include asthma as a health effect in LCIA. 406 
It was emphasized that, in addition to the GBD 2010 effort, there is a large European 407 
movement to decide which health effects associated with PM2.5 exposure to quantify. This 408 
involves two projects
3
 – the Health Risks of Air Pollution in Europe, HRAPIE (WHO 2013a), 409 
and Review of Evidence on Health Aspects of Air Pollution, REVIHAAP (WHO 2013b). 410 
These projects aim to provide advice in support of the comprehensive review of European 411 
Union’s air quality policies scheduled for 2013. A consensus document reflecting this effort 412 
was published end of 2013 (WHO 2013a). Whereas the GBD 2010 effort focuses on cause-413 
specific mortality, the HRAPIE/REVIHAAP projects recommend all-cause analysis as 414 
primary choice and cause-specific analysis as alternative method based on similarity of the 415 
frequency of the causes of death linked with exposure between considered cohorts and 416 
countries. It can be argued that a cause-specific assessment is particularly important in global 417 
assessments because of the large geographical variability in the relative importance of various 418 
causes of death. This view is supported by several studies (Lipsett et al. 2011, Miller et al. 419 
2007, Puett et al. 2011, Puett et al. 2009). 420 
Considering these different approaches, workshop participants agreed to recommend that 421 
LCIA should assess cause-specific mortality, when feasible, whereas all-cause mortality along 422 
with an appropriate assessment of uncertainty might still be useful in case of inconclusive 423 
allocation to causes. Furthermore, health effects considered in GBD 2010 and in the HRAPIE 424 
consensus document should serve as a starting point. 425 
 426 
6.3 Shape of exposure-response functions 427 
In current LCIA practice, the shape of population ERF is usually assumed to be linear 428 
with no threshold. This approach is supported by several studies which find no evidence of a 429 
departure from linearity (Chen et al. 2013, Schwartz et al. 2008, Stafoggia et al. 2013, WHO 430 
2006) and no evidence suggesting a threshold at the population level (COMEAP 2009, 2010). 431 
Despite this, when these linear functions are applied to the very high PM2.5 levels often found 432 
in developing countries, the estimates of risk are so high as to be implausible (Abrahamowicz 433 
et al. 2003, EC 2010b). Recently, several research groups have suggested non-linear ERF that 434 
could be applied across a large range of PM2.5 concentrations, from very low to very high 435 
PM2.5 concentrations. These are typically steep at low concentration levels and relatively flat 436 
                                                 
3
 http://www.euro.who.int/en/what-we-do/health-topics/environment-and-health/air-quality/activities/health-
aspects-of-air-pollution-and-review-of-eu-policies-the-revihaap-and-hrapie-projects 
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at high levels (Abrahamowicz et al. 2003, Burnett et al. 2014, Ostro 2004, Pope III et al. 437 
2009). Whether, and if so, how this approach can be adapted for use in LCIA needs to be 438 
further discussed, acknowledging that LCA aims to support decisions in regions with low 439 
concentration levels and also in regions with high concentration levels. From a sustainability 440 
point of view, intervention in highly polluted areas may be a priority despite the lower 441 
response per unit exposure. Significant departures from linearity would imply that iF would 442 
need to be reconstructed in a manner that is stratified by PM2.5 concentration or other relevant 443 
factors. In making such a change, it is also important to realize that the shape of the ERF 444 
might be effect-specific – for example nearly linear for lung cancer, but substantially non-445 
linear for cardiovascular mortality (Pope III et al. 2011). In GBD 2010, effect-specific, 446 
integrated ERF are proposed for PM2.5 (Lim et al. 2012). These ERF express relative risk as 447 
an exponential function (or a power function) of PM2.5 concentration (Burnett et al. 2014). In 448 
order to apply such non-linear ERF in LCIA, non-linear models can either be directly applied 449 
as e.g. in van Zelm et al. (2008) for ozone formation or be decomposed into piecewise linear 450 
functions. Workshop participants explained that methods for applying this approach are 451 
currently being developed. 452 
In summary, it was agreed to further discuss how the ERF from GBD 2010 together with 453 
recommendations from the HRAPIE project can be adapted to serve as starting points. 454 
Thereby, workshop participants acknowledge that the slope of any linear ERF will vary as a 455 
function of different PM2.5 concentration ranges. LCIA methods will therefore need to be 456 
developed which can account for the variation in background levels of ambient PM2.5 around 457 
the world. This is challenging because in an LCA framework, the exact geographical 458 
locations of individual emission sources are typically unknown (Finnveden et al. 2009, 459 
Hauschild 2005, Humbert et al. 2011). Even if the source locations were known, the LCA 460 
analyst would need to integrate concentrations (and risks) over large areas, including 461 
individuals quite close to the source as well as those far from the source, to capture the entire 462 
exposed population. In principle, this can be addressed by treating the location of the emission 463 
source as uncertain and computing the distribution of possible impacts and recognizing this as 464 
a source of uncertainty in estimates of health impact. 465 
 466 
6.4 Particle characteristics and differential toxicity 467 
PM2.5 mass is commonly used as an indicator of the risk associated with exposure to a 468 
mixture of particle-related pollutants (of different sizes below 2.5 µm diameter) from diverse 469 
(primary or secondary) sources and in different environments (COMEAP 2009, Lim et al. 470 
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2012, Pope III et al. 2009, Pope III et al. 2011). This approach, which implicitly assumes 471 
equal toxicity of PM2.5 constituents per mass unit, is commonly used in LCIA (Potting et al. 472 
2007). There is currently no scientific consensus on the relative toxicity of various 473 
constituents of PM2.5. This, however, does not suggest that all particle constituents are in fact 474 
equally toxic, but instead that the toxicological and epidemiological evidence of differential 475 
toxicity is inconclusive (Hurley et al. 2005). One study found differential toxicity of multiple 476 
particle constituents for short-term exposure effects on hospital admissions (Levy et al. 2012), 477 
but further research is required to address other health outcomes, long-term exposure, and 478 
other geographical settings (Rohr & Wyzga 2012). 479 
In view of this it was agreed to use PM2.5 mass as an indicator of exposure without 480 
differentiating between and among primary and secondary PM2.5 and without differentiating 481 
between different PM2.5 constituents in terms of toxicity for cause-specific chronic mortality 482 
effects. However, the workshop participants understood that given the current state of 483 
scientific uncertainty about this matter it would be important to develop an approach for 484 
characterizing the uncertainty of the toxicity of various constituents of PM2.5 which reflects 485 
the lack of knowledge about which constituents of PM2.5 are in fact responsible for the 486 
toxicity of the mixture. 487 
Another aspect in the discussion of particle characteristics is particle size. Experimental 488 
studies suggest that health effects from exposure to the ultrafine particle (UFP) fraction differ 489 
from those of larger particles due to distinct deposition patterns in the lung and clearance 490 
mechanisms (Oberdörster et al. 2005). There is epidemiological and toxicological evidence 491 
for specific adverse respiratory and cardiovascular effects from exposure to UFP (Delfino et 492 
al. 2005, Weichenthal et al. 2007). However, the limited evidence currently available is 493 
inconsistent for short-term exposure and does not yet address the impacts of long-term 494 
exposure (Rückerl et al. 2011). Thus, it is not yet possible to determine how health effects 495 
associated with exposure to UFP differ from those associated with exposure to larger particles 496 
(HEI 2013). Moreover, there is only limited literature that would allow for calculating iF for 497 
UFP, which is generally characterized by particle number rather than particle mass. 498 
As a result, workshop participants decided not to separately incorporate UFP into LCIA 499 
at present, but suggested that in the future a correction factor might be introduced to account 500 
for the distribution of particle sizes. 501 
 502 
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7 Conclusions and next steps 503 
7.1 Conclusions 504 
Workshop participants discussed the questions shown in Table 1 in an effort to find ways 505 
to refine and improve the overall framework and to suggest data and models that could 506 
harmonize the analysis of health impacts from exposure to ambient particulate matter. This 507 
discussion constituted a first step towards developing recommendations for addressing the 508 
health effects from exposure associated with emissions of primary PM2.5 and secondary PM2.5 509 
precursors in LCIA. A set of 10 recommendations reflecting the consensus of workshop 510 
participants are summarized as follows: 511 
 The intake fraction framework proposed by Humbert et al. (2011) provides a useful 512 
starting point for assessing health effects of ambient PM in LCIA with a focus on PM2.5. 513 
 Human intake fractions can be used to estimate emission-related population exposure. In 514 
conjunction with population-averaged breathing rates, intake fractions can be used to 515 
estimate intake from air concentrations. 516 
 Disability-adjusted life years without age-weighting or discounting, which aggregate 517 
mortality and morbidity, can be used as a summary health metric. 518 
 For most cases, where emission locations are unknown, exposure scenario archetypes 519 
provide a useful approach to account for factors, such as population density, emission 520 
height, and exposure to PM2.5 from indoor sources, which influence human intake 521 
fractions. The decision whether additional archetypes are necessary should be based on a 522 
sensitivity analysis that considers the importance of these additional factors in reducing 523 
uncertainty in exposure estimates. When the exact emission location is known, spatially 524 
explicit fate and transport models should be used. 525 
 Geographical archetypes of intake fractions should be established for indoor, near-field, 526 
neighborhood, urban, regional, and continental scales. Geographical differentiation 527 
should be further discussed and analyzed with respect to scale and non-linear chemical 528 
processes in the formation of secondary PM2.5. 529 
 Emission-weighted average intake fractions should be used in cases where the nature of 530 
the emission sources and/or exposure conditions is unclear. 531 
 The Global Burden of Disease Study 2010 is considered to provide a useful starting point 532 
for developing exposure-response functions for assessing PM2.5-related health effects in 533 
LCIA. 534 
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 Cause-specific mortality can provide a more informative basis for developing LCIA 535 
characterization factors than all-cause mortality. Assumptions for age- and cause-specific 536 
disability weights should be further discussed and analyzed. 537 
 Non-linear exposure-response functions are recommended in the Global Burden of 538 
Disease Study 2010, whereas linear functions are used in the consensus document of the 539 
Health Risks of Air Pollution in Europe projects. There remains a need for discussion 540 
about whether, and if so, how to integrate non-linear (or piecewise linear) exposure-541 
response functions into LCIA. 542 
 PM2.5 mass can be used as the indicator of the health risk associated with PM inhalation 543 
exposure in LCIA. There is no justification at this time to differentiate between different 544 
primary/secondary PM2.5 sources or between different PM2.5 particle sizes regarding 545 
toxicity. However, analyses should report the uncertainties inherent in any assumptions 546 
made about the relative toxicity of various types of particles. 547 
 548 
7.2 Next steps 549 
Within the next two years, the goals of the task force on human health impacts are to 550 
build a global guidance framework and to determine characterization factors for incorporating 551 
the health effects from exposure to PM2.5 in LCIA and for including both indoor and outdoor 552 
releases. As next steps towards these goals, the first set of recommendations from the Basel 553 
Guidance Workshop will be taken. Open questions and unsolved problems will be further 554 
studied that were pointed out by workshop participants and the proposed framework will be 555 
refined based on best available data and methods. The harmonized framework and related 556 
results will finally be presented at a Pellston Technical Workshop
4
 in 2015.557 
                                                 
4
 Pellston Workshops are preeminent workshops held by the SETAC, each of which brings together leading 
scientists from academia, business, and governments around the world and focuses on a relevant environmental 
topic with proceedings published as a peer-reviewed report, book or journal article compilation. 
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